mRNA |
JQ-1:vorinostat (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0008 |
mRNA |
AZD8055 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0008 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0009 |
mRNA |
staurosporine |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
0.001 |
mRNA |
BRD-K75293299 |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
0.001 |
mRNA |
968 |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
0.001 |
mRNA |
FK866 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
mRNA |
MLN2480 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
0.001 |
mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.002 |